US Stock MarketDetailed Quotes

DAWN Day One Biopharmaceuticals

Watchlist
  • 14.090
  • +0.410+3.00%
Close Aug 23 16:00 ET
  • 14.090
  • 0.0000.00%
Post 19:18 ET
1.39BMarket Cap-7262P/E (TTM)

Day One Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Day One Biopharmaceuticals Q2 2024 Earnings Date

Currency：USDJul 30, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
912.22K
8.19M
+7.28M
Beat Est.
--
--
+798.03%
EPS
-0.75
-0.05
+0.70
Beat Est.
-23.17%
+91.80%
+93.34%
Analyst Rating
Strong Buy

Aug 23, 2024

Day One Biopharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 16.425M--
--2024/Q3-- / 26.483M--
Jul 30, 20242024/Q28.192M / 912.220K--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 16.425M--
--2024/Q3-- / 26.483M--
Jul 30, 20242024/Q28.192M / 912.220K--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Day One Biopharmaceuticals Earnings Reports

  • Day One Biopharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 2 16:13 ET

  • Day One Biopharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 6 16:41 ET

  • Day One Biopharmaceuticals | 10-K: FY2023 Annual Report

    Feb 26 22:24 ET

  • Day One Biopharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 6, 2023 16:48 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 23, 2024

    Strong Buy

    • Buy

      90.91%

    • Hold

      9.09%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg